{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:40:04Z","timestamp":1754062804764,"version":"3.41.2"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Human papillomavirus (HPV) vaccination has been offered in over a hundred countries worldwide (including the United Kingdom, since September 2008). Controversy around adverse effects persists, with inconsistent evidence from follow-up of randomized controlled trials and confounding by indication limiting the conclusions drawn from larger-scale observational studies. This study aims to estimate the association between receiving a quadrivalent HPV vaccine and the reporting of short-term adverse effects and to demonstrate the utility of regression discontinuity design for examining side effects in routine data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We applied a novel regression discontinuity approach to a retrospective population-based cohort using primary care data from the UK Clinical Practice Research Datalink linked to hospital and social deprivation data. We examined the new onset of gastrointestinal, neuromuscular, pain, and headache\/migraine symptoms using READ and International Classification of Diseases, tenth revision diagnostic codes. For each year between 2012 and 2017, we compared girls in school year 8 (born July\/August) who were eligible to receive the vaccine with girls in year 7 (born September\/October) who were not eligible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 21,853 adolescent girls in the cohort, 10,881 (50%) were eligible for HPV vaccination. There was no evidence of increased new gastrointestinal symptoms (adjusted odds ratio [OR]: 0.99; 95% confidence interval [CI]: 0.85, 1.15), headache\/migraine symptoms (OR: 0.84; 95% CI: 0.70, 1.01), or pain symptoms (OR: 1.05; 95% CI: 0.95, 1.16) when comparing those eligible and ineligible for HPV vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study found no evidence that HPV vaccination eligibility is associated with reporting short-term adverse effects among adolescent girls.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001784","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T12:17:44Z","timestamp":1727957864000},"page":"813-822","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the Potential Short-term Adverse Effects of the Quadrivalent Human Papillomavirus Vaccine: A Novel Regression Discontinuity Analysis"],"prefix":"10.1097","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7914-8037","authenticated-orcid":false,"given":"Ruta","family":"Margelyte","sequence":"first","affiliation":[{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-0874","authenticated-orcid":false,"given":"Maria Theresa","family":"Redaniel","sequence":"additional","affiliation":[{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-6301","authenticated-orcid":false,"given":"Scott R.","family":"Walter","sequence":"additional","affiliation":[{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Pyne","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-9087","authenticated-orcid":false,"given":"Sam","family":"Merriel","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"},{"name":"College of Medicine and Health, University of Exeter, Exeter, United Kingdom."},{"name":"Centre for Primary Care & Health Services Research, University of Manchester, Manchester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-1144","authenticated-orcid":false,"given":"John","family":"Macleod","sequence":"additional","affiliation":[{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0602-1983","authenticated-orcid":false,"given":"Kate","family":"Northstone","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1010-8926","authenticated-orcid":false,"given":"Kate","family":"Tilling","sequence":"additional","affiliation":[{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers.","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjc.6603695","article-title":"Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer.","volume":"96","author":"Stanley","year":"2007","journal-title":"Br J Cancer"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.","volume":"116","author":"Palmer","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12026-016-8855-1","article-title":"Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination.","volume":"65","author":"Blitshteyn","year":"2017","journal-title":"Immunol Res"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","article-title":"Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papillomavirus.","volume":"33","author":"Brinth","year":"2015","journal-title":"Vaccine"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/CND.0000000000000130","article-title":"Small fiber neuropathy following vaccination.","volume":"18","author":"Kafaie","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2169\/internalmedicine.53.3133","article-title":"Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine.","volume":"53","author":"Kinoshita","year":"2014","journal-title":"Intern Med"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/RHU.0000000000000165","article-title":"Fibromyalgia-like illness in 2 girls after human papillomavirus vaccination.","volume":"20","author":"Martinez-Lavin","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12026-016-8820-z","article-title":"Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature.","volume":"65","author":"Palmieri","year":"2017","journal-title":"Immunol Res"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/archdischild-2011-301307","article-title":"Complex regional pain syndrome following immunisation.","volume":"97","author":"Richards","year":"2012","journal-title":"Arch Dis Child"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0009922817728701","article-title":"Autoimmunity, autonomic neuropathy, and the HPV vaccination: a vulnerable subpopulation.","volume":"57","author":"Schofield","year":"2018","journal-title":"Clin Pediatr (Phila)"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"2324709614527812","DOI":"10.1177\/2324709614527812","article-title":"Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the \u201cautoimmune\/auto-inflammatory syndrome induced by adjuvants\u201d: case report and literature review.","volume":"2","author":"Tomljenovic","year":"2014","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40264-017-0625-z","article-title":"Safety of human papillomavirus vaccines: an updated review.","volume":"41","author":"Phillips","year":"2018","journal-title":"Drug Saf"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"f5906","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.","volume":"347","author":"Arnheim-Dahlstrom","year":"2013","journal-title":"BMJ"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2017.06.030","article-title":"Human papillomavirus vaccination and risk of autoimmune diseases: a large cohort study of over 2 million young girls in France.","volume":"35","author":"Miranda","year":"2017","journal-title":"Vaccine"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmv.27304","article-title":"The comparative safety of human papillomavirus vaccines: a Bayesian network meta-analysis.","volume":"94","author":"Huang","year":"2022","journal-title":"J Med Virol"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/aje\/kwz043","article-title":"Evaluating the effectiveness of vaccines using a regression discontinuity design.","volume":"188","author":"Basta","year":"2019","journal-title":"Am J Epidemiol"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/EDE.0000000000000138","article-title":"Regression discontinuity designs in epidemiology: causal inference without randomized trials.","volume":"25","author":"Bor","year":"2014","journal-title":"Epidemiology"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jclinepi.2016.11.008","article-title":"The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects.","volume":"82","author":"Maas","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"g5293","DOI":"10.1136\/bmj.g5293","article-title":"Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data.","volume":"349","author":"O\u2019Keeffe","year":"2014","journal-title":"BMJ"},{"key":"R27-20250801","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/EDE.0000000000000145","article-title":"Commentary: regression discontinuity design: let\u2019s give it a try to evaluate medical and public health interventions.","volume":"25","author":"Vandenbroucke","year":"2014","journal-title":"Epidemiology"},{"key":"R28-20250801","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1503\/cmaj.140900","article-title":"Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV vaccine cohort study.","volume":"187","author":"Smith","year":"2015","journal-title":"CMAJ"},{"key":"R29-20250801","doi-asserted-by":"crossref","first-page":"e1131","DOI":"10.1542\/peds.2014-2961","article-title":"The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts.","volume":"135","author":"Smith","year":"2015","journal-title":"Pediatrics"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jclinepi.2014.06.021","article-title":"Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice.","volume":"68","author":"Moscoe","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.vaccine.2013.08.024","article-title":"Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK.","volume":"31","author":"Donegan","year":"2013","journal-title":"Vaccine"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1080\/21645515.2016.1199308","article-title":"Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16\/18 AS04-adjuvanted vaccine in the United Kingdom.","volume":"12","author":"Willame","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R33-20250801","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1016\/j.vaccine.2015.07.024","article-title":"Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16\/18 AS04-adjuvanted vaccine in the United Kingdom.","volume":"33","author":"Baril","year":"2015","journal-title":"Vaccine"},{"key":"R34-20250801","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.vaccine.2017.01.076","article-title":"No increased risk of Guillain-Barre syndrome after human papillomavirus vaccine: a self-controlled case-series study in England.","volume":"35","author":"Andrews","year":"2017","journal-title":"Vaccine"},{"key":"R37-20250801","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R38-20250801","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5662\/wjm.v2.i4.27","article-title":"Statistical models for meta-analysis: a brief tutorial.","volume":"2","author":"Kelley","year":"2012","journal-title":"World J Methodol"},{"key":"R40-20250801","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jeconom.2007.05.001","article-title":"Regression discontinuity designs: a guide to practice.","volume":"142","author":"Imbens","year":"2008","journal-title":"J Econometrics"},{"key":"R43-20250801","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD).","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R45-20250801","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/0305792022000002170","article-title":"Comparing school systems to explain enduring birth date effects: a response to McDonald (2001).","volume":"32","author":"Sharp","year":"2002","journal-title":"Compare"},{"key":"R46-20250801","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fpsyg.2018.01482","article-title":"A review of the academic and psychological impact of the transition to secondary education.","volume":"9","author":"Evans","year":"2018","journal-title":"Front Psychol"},{"key":"R47-20250801","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jebo.2019.10.005","article-title":"Long-lasting effects of relative age at school.","volume":"168","author":"Page","year":"2019","journal-title":"J Econ Behav Organ"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:05:02Z","timestamp":1754060702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001784","relation":{},"ISSN":["1044-3983","1531-5487"],"issn-type":[{"type":"print","value":"1044-3983"},{"type":"electronic","value":"1531-5487"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}